Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-01-10 01:01:23 UTC |
---|
Updated at | 2022-01-10 01:11:26 UTC |
---|
NP-MRD ID | NP0044222 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 2-Deoxyadenosine |
---|
Description | Deoxyadenosine, also known as dA, belongs to the class of organic compounds known as purine 2'-deoxyribonucleosides. Purine 2'-deoxyribonucleosides are compounds consisting of a purine linked to a ribose which lacks a hydroxyl group at position 2. Deoxyadenosine exists in all living species, ranging from bacteria to plants to humans. In humans, deoxyadenosine is involved in the mercaptopurine action pathway. Deoxyadenosine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Deoxyadenosine, with regard to humans, has been found to be associated with several diseases such as colorectal cancer and eosinophilic esophagitis; deoxyadenosine has also been linked to several inborn metabolic disorders including adenosine deaminase deficiency and adenylosuccinate lyase deficiency. It was first documented in 2015 (PMID: 25971195). Based on a literature review a significant number of articles have been published on Deoxyadenosine (PMID: 34514267) (PMID: 34552805) (PMID: 34519921) (PMID: 34516245). |
---|
Structure | NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC=N1 InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1 |
---|
Synonyms | Value | Source |
---|
(2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol | ChEBI | 5-(6-AMINO-purin-9-yl)-2-hydroxymethyl-tetrahydro-furan-3-ol | ChEBI | 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)adenine | ChEBI | 9-(2-Deoxy-beta-D-ribofuranosyl)-9H-purin-6-amine | ChEBI | Adenine deoxyribonucleoside | ChEBI | Adenyldeoxyriboside | ChEBI | dA | ChEBI | 2'-Deoxyadenosine | Kegg | 9-(2-Deoxy-b-D-erythro-pentofuranosyl)adenine | Generator | 9-(2-Deoxy-β-D-erythro-pentofuranosyl)adenine | Generator | 9-(2-Deoxy-b-D-ribofuranosyl)-9H-purin-6-amine | Generator | 9-(2-Deoxy-β-D-ribofuranosyl)-9H-purin-6-amine | Generator | 1-(6-Amino-9H-purin-9-yl)-1,2-dideoxy-b-D-ribofuranose | HMDB | 1-(6-Amino-9H-purin-9-yl)-1,2-dideoxy-beta-D-ribofuranose | HMDB | 1-(6-Amino-9H-purin-9-yl)-1,2-dideoxy-beta-delta-ribofuranose | HMDB | 2-Deoxyadenosine | HMDB | 9-(2-Deoxy-b-D-erythro-pentofuranosyl)-9H-purin-6-amine | HMDB | 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)-9H-purin-6-amine | HMDB | 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-9H-purin-6-amine | HMDB | 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)adenine | HMDB | 9-(2-Deoxy-beta-delta-ribofuranosyl)-9H-purin-6-amine | HMDB | Adenine deoxyribose | HMDB | Adenine-9 2-deoxy-b-D-erythro-pentofuranoside | HMDB | Adenine-9 2-deoxy-beta-D-erythro-pentofuranoside | HMDB | Adenine-9 2-deoxy-beta-delta-erythro-pentofuranoside | HMDB | Desoxyadenosine | HMDB | Deoxyadenosine | ChEBI |
|
---|
Chemical Formula | C10H13N5O3 |
---|
Average Mass | 251.2419 Da |
---|
Monoisotopic Mass | 251.10184 Da |
---|
IUPAC Name | (2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol |
---|
Traditional Name | 2-deoxyadenosine |
---|
CAS Registry Number | Not Available |
---|
SMILES | NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC=N1 |
---|
InChI Identifier | InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1 |
---|
InChI Key | OLXZPDWKRNYJJZ-RRKCRQDMSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, simulated) | Ahselim | | | 2022-01-10 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, experimental) | Ahselim | | | 2022-01-10 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as purine 2'-deoxyribonucleosides. Purine 2'-deoxyribonucleosides are compounds consisting of a purine linked to a ribose which lacks a hydroxyl group at position 2. |
---|
Kingdom | Organic compounds |
---|
Super Class | Nucleosides, nucleotides, and analogues |
---|
Class | Purine nucleosides |
---|
Sub Class | Purine 2'-deoxyribonucleosides |
---|
Direct Parent | Purine 2'-deoxyribonucleosides |
---|
Alternative Parents | |
---|
Substituents | - Purine 2'-deoxyribonucleoside
- 6-aminopurine
- Imidazopyrimidine
- Purine
- Aminopyrimidine
- N-substituted imidazole
- Pyrimidine
- Imidolactam
- Azole
- Imidazole
- Heteroaromatic compound
- Tetrahydrofuran
- Secondary alcohol
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Amine
- Primary amine
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Alcohol
- Organic nitrogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Rebollar-Ramos D, Ovalle-Magallanes B, Palacios-Espinosa JF, Macias-Rubalcava ML, Raja HA, Gonzalez-Andrade M, Mata R: alpha-Glucosidase and PTP-1B Inhibitors from Malbranchea dendritica. ACS Omega. 2021 Aug 25;6(35):22969-22981. doi: 10.1021/acsomega.1c03708. eCollection 2021 Sep 7. [PubMed:34514267 ]
- Zhang BH, Chen W, Li HQ, Zhou EM, Hu WY, Duan YQ, Mohamad OA, Gao R, Li WJ: An antialgal compound produced by Streptomyces jiujiangensis JXJ 0074(T). Appl Microbiol Biotechnol. 2015 Sep;99(18):7673-83. doi: 10.1007/s00253-015-6584-3. Epub 2015 May 14. [PubMed:25971195 ]
- Yong L, Leng AQ, Yang ZX, Xue Y: A Practical Method for Determination of Nine Nucleosides in Tricholoma matsutake by UPLC/MS and Quantitative Analysis of Multicomponents Using Single Marker Method. J Anal Methods Chem. 2021 Sep 11;2021:9571329. doi: 10.1155/2021/9571329. eCollection 2021. [PubMed:34552805 ]
- Tan G, Fei Z, Wei R, Wu X, Xiao P: Development of a Novel Bioluminescence Pyrophosphate Assay for the High-Sensitivity Detection of Hepatitis B Virus. Appl Biochem Biotechnol. 2021 Sep 14. pii: 10.1007/s12010-021-03655-0. doi: 10.1007/s12010-021-03655-0. [PubMed:34519921 ]
- Cilento ME, Reeve AB, Michailidis E, Ilina TV, Nagy E, Mitsuya H, Parniak MA, Tedbury PR, Sarafianos SG: Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant Strains. Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0116721. doi: 10.1128/AAC.01167-21. Epub 2021 Sep 13. [PubMed:34516245 ]
|
---|